ENTOS
LIVE

Serial Number

97980623

Owner

Entos Pharmaceuticals Inc.

Attorney

Theodore R. Remaklus

First Use Date

Jan 31, 2019

Filing Date

Sep 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ENTOS Trademark

Serial Number: 97980623 • Registration: 8215234

ENTOS is a trademark filed by Entos Pharmaceuticals Inc. on September 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Entos Pharmaceuticals Inc.

10230 Jasper Avenue, Unit 4550
Edmonton, Alberta T5J4P6 , CA

Entity Type: 03

Trademark Details

Filing Date

September 14, 2022

Registration Date

April 14, 2026

First Use Anywhere

January 31, 2019

First Use in Commerce

January 31, 2019

Published for Opposition

May 7, 2024

Goods & Services

Pharmaceutical and medicinal preparations and substances, namely, human vaccines; chronic diseases, namely, chronic neurological and nervous system diseases and other mental illnesses, chronic eye diseases, chronic muscle diseases, and cancers in the nature of hematological cancers and solid organ cancers; vaccines that are viral, bacterial, fungal for human use; therapeutic and preventative cancer vaccines for human use; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of a variety of diseases and disorders, namely, inflammatory muscle diseases and disorders, diabetes, obesity, metabolic diseases and disorders, namely, metabolic enzyme deficiencies, diabetes, muscular dystrophy, genetic diseases and disorders, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, respiratory diseases and disorders, rare and orphan diseases, and rare genetic diseases and disorders, namely, rare respiratory, pulmonary and lung diseases, rare liver diseases, rare eye diseases, rare muscle diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 14, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 14, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 28, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 28, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 5, 2025 SUPC
DIVISIONAL PROCESSING COMPLETE
Sep 5, 2025 DPCC
USE AMENDMENT FILED
Jun 30, 2025 IUAF
DIVISIONAL REQUEST RECEIVED
Jun 30, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 30, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Jun 30, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 7, 2025 EX1G
SOU EXTENSION 1 FILED
Dec 30, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 30, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 7, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 7, 2024 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 28, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 12, 2024 XAEC
ASSIGNED TO LIE
Mar 11, 2024 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2024 CNEA
DIVISIONAL PROCESSING COMPLETE
Mar 8, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 6, 2024 AITU
DIVISIONAL REQUEST RECEIVED
Nov 16, 2023 DRRR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2023 TROA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 16, 2023 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 16, 2023 PARI
TEAS REQUEST TO DIVIDE RECEIVED
Nov 16, 2023 ERTD
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 27, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2022 NWOS
NEW APPLICATION ENTERED
Sep 17, 2022 NWAP